United States · 
Who invested in FibroBiologics?
FibroBiologics's investors include The Global Emerging Markets Gem.
2026
$1.7MRound$3.0MRound
United States · Funded startup
Who invested in FibroBiologics
Funding summaryUpdated 26 Oct 2026
$4.7Mraised across 2 rounds since 2025, from 4 sources
$1.7MRound$3.0MRound
- Latest round
- Round, $3.0MJun 2026
- Step-upi
- 1.8×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $1.7M Dec 2025
- Biggest round
- $3.0M Round · Jun 2026
- Between rounds
- 6 months from the last two
The rounds
- Jun 2026
- Dec 2025Round$1.7M1 new
Source recorded and 2 othersSEC filing: $1.5M sold, first sale Nov 2025
Funding filed with regulators
FibroBiologics filed one raise, $4.9M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Apr 2023$4.9MCrowdfunding
Founders and team
From FibroBiologics's own website: 1 founder, 3 on the team.
Pete O’HeeronChairman/Founder/CEO
- Jason D. DavisChief Financial Officer
- Leigh SteinbergBoard of Directors
- Robert E. HoffmanBoard of Directors
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about FibroBiologics
How much has FibroBiologics raised?
FibroBiologics has raised $4.7M across 2 rounds since 2025.
When did FibroBiologics last raise?
FibroBiologics's most recent round was an Undisclosed round of $3.0M in Jun 2026.
What was FibroBiologics's biggest round?
Its most recent round, $3.0M in Jun 2026, is also its largest on record.
Who backed FibroBiologics first?
FibroBiologics's first round on record, in Dec 2025, was backed by The Global Emerging Markets Gem.
What stage is FibroBiologics at?
FibroBiologics's latest named round is an Undisclosed round, in Jun 2026.
Where is FibroBiologics based?
FibroBiologics is based in the United States.
Companies like FibroBiologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.